Madrid

• An Open-label, Multicenter, Phase 1a/1b Study to Evaluate the Safety and Anti-tumor Activity of TT125-802 in Combination With Adagrasib, Osi … Pending
  2024-519071-25-00 3 Advanced NSCLC
• REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis. Pending
  2024-519298-21-00 5 Cancer-Associated Thrombosis (CAT).
• A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have compl … Pending
  2024-519638-22-00 5 IgA nephropathy
• Moonlanding: A phase 2 study of pembrolizumab plus belzutifan, with or without lenvatinib, given before the main treatment for localized kid … Pending
  2024-519673-18-00 4 Patients with localized renal cell carcinoma
• Clinical Trial to evaluate the efficacy and safety of cell therapy for dry eye disease in Graft-versus-Host Disease (GvHD) context. Pending
  2024-519772-10-00 4 Dry eye disease in patients with Graft versus Host disease patients
• A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cel … Pending
  2024-519786-22-01 9 metastatic non-small cell lung cancer (NSCLC)
• A trial to learn how well sonesitatug vedotin and capecitabine with or without rilvegostomig work and how safe they are in adults with cance … Pending
  2024-519787-40-00 5 Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal C
• efficacy and safety of the use of regulatory T cells in immune hyperactivation in patients with COVID-19 and/or acute respiratory distress s … Pending
  2024-519799-25-00 7 immune hyperactivation in COVID-19 patients and/or acute respiratory d
• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants with Moderate-to-Severe Atopic Dermatitis (ADAPTIVE) Pending
  2024-520117-50-00 4 Atopic Dermatitis
• A Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute M … Pending
  2024-520125-36-00 3 Relapsed or Refractory Acute Myeloid Leukemia; Acute Myeloid Leukemia
• An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending
  2024-520218-23-00 10 Pulmonary Arterial Hypertension
• CITY Pending
  2024-520294-13-00 1 Cutaneous T-cell lymphomas (CTCL)
• Clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas Pending
  2024-520318-23-00 9 Patients with advanced soft-tissue sarcoma (leiomyosarcoma or malignan
• A multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients: efficacy and microbiologi … Pending
  2024-520336-14-00 5 Post-chemotherapy neutropenia with high risk of developing infection i
• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease
• A study to learn how safe AZD6621 is, how well it works, and how it moves throughout the body over time, in adult male participants with Met … Pending
  2025-520626-37-00 7 Metastatic Prostate Cancer
• A Study to Assess the Safety of RG6496 in Huntington’s Disease Gene Expansion Carriers with the Selected Genetic Variant (POINT-HD) Pending
  2025-520631-17-00 1 Huntington’s Disease Gene Expansion Carriers
• Role of inhaled nitric oxide on right ventricular function and pulmonary vascular mechanics following cardiac surgery Pending
  2025-520808-10-00 5 Patients in the immediate cardiac surgery post-operative period
• Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES s … Pending
  2025-520954-12-00 6 Atrial Fibrillation Device thrombosis post-Left Atrial Appendage Closu
• Effects of sodium-glucose cotransporter 2 inhibition on the mechanisms of heart failure with preserved ejection fraction Pending
  2025-520969-51-00 6 Heart failure with preserved ejection fraction
• A clinical trial to learn how liver function affects the blood levels of DAK539 in people with advanced cancer Pending
  2025-521001-40-00 3 Advanced Malignancies and Hepatic Impairment
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending
  2025-521037-86-00 5 Immune system diseases
• A Study to Evaluate the Safety and Tolerability of ARV-806 in Adults with Advanced Cancer that has the KRAS G12D Mutation Pending
  2025-521062-10-00 1 KRAS G12D Mutated Advanced Solid Tumors
• Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with … Pending
  2025-521086-28-00 6 CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arthritis or psoria

Showing 97–120 of 3,599 trials